Get started
Author

Daniela Weiler

Observed name: D. Weiler
Observed institution: Luzerner Kantonsspital
ORCID: 0009-0007-8059-7861
Observed ORCID: 0009-0007-8059-7861
OpenAlex ID: A5082955073
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
2024 · Lori J. Wirth, Marcia S. Brose, et al. · Journal of Clinical Oncology · 57
PDF
Rapid Response to Trastuzumab Emtansine in a Patient with HER2-Driven Lung Cancer
2015 · Daniela Weiler, Joachim Diebold, et al. · Journal of Thoracic Oncology · 32
PDF
Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update.
2021 · Eric Jeffrey Sherman, Lori J. Wirth, et al. · Journal of Clinical Oncology · 11
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma
2024 · Daniela Weiler, Maria del Sol Pérez Lago · European Journal of Nuclear Medicine and Molecular Imaging · 10
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET -Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al. · Clinical Cancer Research · 4
Efficacy of selpercatinib after prior systemic therapy in patients with RET mutant medullary thyroid cancer.
2021 · Lori J. Wirth, Eric Jeffrey Sherman, et al. · Journal of Clinical Oncology · 3
[Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations].
2011 · Benjamin M Heuberger, Daniela Weiler, et al. · PubMed · 3
PP01.08: Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al. · Journal of Thoracic Oncology · 1
Table S2 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al.
Table S1 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al.
Supplementary Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al.
Table S3 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al.
Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium
2026 · Sarah Waliany, Alissa J. Cooper, et al.
Corrigendum to “Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life”
2025 · S. Zimmermann, S. Aebi, et al. · ESMO Real World Data and Digital Oncology
PDF
[Large retroperitoneal mass in a young patient].
2025 · Kilian Meier, Daniela Weiler · PubMed
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life
2025 · S. Zimmermann, S. Aebi, et al. · ESMO Real World Data and Digital Oncology
PDF
Prevalence of Functional Iron Deficiency (FID) in Patients With Malignancies Independent of Haemoglobin and Age And its Impact on Fatigue-Specific Quality of Life - Results of a Prospective, Observational Single-Centre Study
2024 · Sibylle Zimmermann, Stefan Aebi, et al. · SSRN Electronic Journal
«Less is more» pour les traitements médicamenteux des cancers
2023 · Magdalena Hecz, Stefan Aebi, et al. · Forum Médical Suisse ‒ Swiss Medical Forum
PDF
«Less is more» bei medikamentösen Tumortherapien
2023 · Magdalena Hecz, Stefan Aebi, et al. · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
PDF
Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC)
2020 · Momin Shah, Eric J. Sherman, et al.
Intravascular large B‑cell lymphoma
2016 · Silvia Hofer, Manfred Kessler, et al. · memo - Magazine of European Medical Oncology
Works count: 21
Citation count: 121
H-index: 4
I10-index: 4
Year
Topic
Type